Nancy Hakooz

789 total citations
44 papers, 595 citations indexed

About

Nancy Hakooz is a scholar working on Pharmacology, Molecular Biology and Genetics. According to data from OpenAlex, Nancy Hakooz has authored 44 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 16 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Nancy Hakooz's work include Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (10 papers) and Genetic Associations and Epidemiology (4 papers). Nancy Hakooz is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (10 papers) and Genetic Associations and Epidemiology (4 papers). Nancy Hakooz collaborates with scholars based in Jordan, United States and United Kingdom. Nancy Hakooz's co-authors include David Carlile, J. Brian Houston, Martin K. Bayliss, Rana Dajani, Tawfiq Arafat, Imad I. Hamdan, J. Brian Houston, David Hallifax, Yousef Khader and Laith N. AL‐Eitan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Gene.

In The Last Decade

Nancy Hakooz

41 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Hakooz Jordan 15 318 200 150 82 72 44 595
Amarjit S. Chaudhry United States 17 308 1.0× 207 1.0× 182 1.2× 141 1.7× 47 0.7× 20 737
Hugo Kohnke Sweden 8 479 1.5× 145 0.7× 172 1.1× 113 1.4× 94 1.3× 10 848
Justin D. Lutz United States 16 294 0.9× 219 1.1× 252 1.7× 123 1.5× 82 1.1× 21 838
Jane Sayi Tanzania 15 437 1.4× 231 1.2× 130 0.9× 111 1.4× 66 0.9× 16 752
Susan Wong United States 17 314 1.0× 248 1.2× 220 1.5× 98 1.2× 30 0.4× 39 833
Catherine Spire France 12 370 1.2× 193 1.0× 341 2.3× 75 0.9× 60 0.8× 14 850
Hiromitsu Nakasa Japan 13 333 1.0× 210 1.1× 137 0.9× 111 1.4× 60 0.8× 30 596
Jackie C. Bloomer United Kingdom 13 268 0.8× 180 0.9× 261 1.7× 50 0.6× 47 0.7× 20 751
Lucia F. Jorge-Nebert United States 9 276 0.9× 137 0.7× 186 1.2× 44 0.5× 64 0.9× 11 583
Sang Seop Lee South Korea 20 326 1.0× 327 1.6× 237 1.6× 121 1.5× 103 1.4× 40 859

Countries citing papers authored by Nancy Hakooz

Since Specialization
Citations

This map shows the geographic impact of Nancy Hakooz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Hakooz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Hakooz more than expected).

Fields of papers citing papers by Nancy Hakooz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Hakooz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Hakooz. The network helps show where Nancy Hakooz may publish in the future.

Co-authorship network of co-authors of Nancy Hakooz

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Hakooz. A scholar is included among the top collaborators of Nancy Hakooz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Hakooz. Nancy Hakooz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oni‐Orisan, Akinyemi, et al.. (2025). Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management. Clinical Pharmacology & Therapeutics. 118(6). 1286–1296.
2.
Jarrar, Yazun, et al.. (2025). Genome-wide screening of pharmacogenomic biomarkers in jordanian patients with genetic disorders. The Pharmacogenomics Journal. 25(6). 28–28.
3.
Alsayed, Ahmad R., et al.. (2023). The laboratory parameters in predicting the severity and death of COVID-19 patients: Future pandemic readiness strategies. SHILAP Revista de lepidopterología. 24(2). 238–255. 1 indexed citations
4.
Hakooz, Nancy. (2023). Pharmacogenetics and Personalized Medicines. Jordan Journal of Pharmaceutical Sciences. 16(2). 444–444. 2 indexed citations
5.
Hakooz, Nancy, et al.. (2021). The effect of endurance, resistance training, and supplements on mitochondria and bioenergetics of muscle cells. Journal of Basic and Clinical Physiology and Pharmacology. 33(6). 673–681. 1 indexed citations
6.
AL‐Eitan, Laith N., et al.. (2019). Assessing the forensic efficiency of the GlobalFiler STR loci among the genetically isolated Chechen subpopulation in Jordan. Gene. 720. 144078–144078. 6 indexed citations
7.
AL‐Eitan, Laith N., Heba Saadeh, Nancy Hakooz, et al.. (2019). The genetic landscape of Arab Population, Chechens and Circassians subpopulations from Jordan through HV1 and HV2 regions of mtDNA. Gene. 729. 144314–144314. 1 indexed citations
8.
Hakooz, Nancy, et al.. (2017). Effects of the genetic variants of organic cation transporters 1 and 3 on the pharmacokinetics of metformin in Jordanians. Drug Metabolism and Personalized Therapy. 32(3). 157–162. 22 indexed citations
9.
Dajani, Rana, Jin Li, Zhi Wei, et al.. (2017). Genome-wide association study identifies novel type II diabetes risk loci in Jordan subpopulations. PeerJ. 5. e3618–e3618. 11 indexed citations
10.
Al-Sha’er, Mahmoud A., et al.. (2015). Evaluation of novel Akt1 inhibitors as anticancer agents using virtual co-crystallized pharmacophore generation. Journal of Molecular Graphics and Modelling. 62. 213–225. 20 indexed citations
11.
Al-Sha’er, Mahmoud A., et al.. (2013). 1-[2-Substituted ethyl]-2-methyl-5-nitroimidazole derivatives, synthesis and antibacterial activities. Der pharma chemica. 5(3). 156–162. 2 indexed citations
12.
Dajani, Rana, et al.. (2013). Prevalence of MTHFR C677T Single Nucleotide Polymorphism in Genetically Isolated Populations in Jordan. Biochemical Genetics. 51(9-10). 780–788. 8 indexed citations
13.
Yousef, Al‐Motassem, Nailya Bulatova, William G. Newman, et al.. (2012). Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population. Molecular Biology Reports. 39(10). 9423–9433. 45 indexed citations
14.
Dajani, Rana, et al.. (2012). Diabetes mellitus in genetically isolated populations in Jordan: prevalence, awareness, glycemic control, and associated factors. Journal of Diabetes and its Complications. 26(3). 175–180. 17 indexed citations
15.
16.
Hakooz, Nancy, et al.. (2010). A Trend of Low Serum Vitamin B12 in Jordanian Adults from Two Ethnic Groups in Amman. Jordan Medical Journal. 40(2). 7 indexed citations
17.
Wazaify, Mayyada, Abla Albsoul‐Younes, & Nancy Hakooz. (2010). Improving pharmacy education at the Public Faculties of Pharmacy in Jordan: Students’ experience and expectations. Pharmacy Education. 10. 8 indexed citations
18.
Hakooz, Nancy, Tawfiq Arafat, Debbie Payne, et al.. (2010). Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population. European Journal of Clinical Pharmacology. 66(10). 999–1003. 14 indexed citations
19.
20.
Hakooz, Nancy & Imad I. Hamdan. (2006). Effects of Dietary Broccoli on Human in Vivo Caffeine Metabolism: A Pilot Study on a Group of Jordanian Volunteers. Current Drug Metabolism. 8(1). 9–15. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amarjit S. Chaudhry Breakdown of academic impact, for papers by Hugo Kohnke Breakdown of academic impact, for papers by Justin D. Lutz Breakdown of academic impact, for papers by Jane Sayi Breakdown of academic impact, for papers by Susan Wong Breakdown of academic impact, for papers by Catherine Spire Breakdown of academic impact, for papers by Hiromitsu Nakasa Breakdown of academic impact, for papers by Jackie C. Bloomer Breakdown of academic impact, for papers by Lucia F. Jorge-Nebert Breakdown of academic impact, for papers by Sang Seop Lee
Rankless by CCL
2026